This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: T31.5 (Burns involving 50-59% of body surface) | Special Copayment Reduction: V247 (Severe burn special copayment reduction: 5% copayment for 1 year from the registration date) |
| B. Synonyms | 50-59% TBSA burn, extremely severe burn, massive burn 50-59%, burn of more than half of body surface |
| C. Adult onset | With damage to more than half of the body surface, autologous donor sites are extremely limited, and active use of allografts, cultured epithelium, and artificial skin together with long-term treatment in a burn intensive care unit is essential. |
| 1. History | Almost unsurvivable before the 1970s → survivable after the development of CEA (1979); current survival in specialized centers 60~70% |
| 2. Causes | Large-scale fires, explosions; fires in enclosed spaces are the most lethal; industrial accidents and fuel explosions in traffic accidents |
| 3. Genetics | Genes for intensity of the systemic inflammatory response; insulin resistance; HLA and allografts; survival and genetic diversity |
| 4. General epidemiology | 3~5% of all burn admissions; mortality surges at 50% TBSA or more; mortality 25~40% in young adults |
| 5. Pathophysiology | Severe burn shock; absolute shortage of autologous donor sites; recurrent sepsis; cascading ARDS, AKI, and liver failure |
| 6. Symptoms | Severe pain/symptoms of shock, respiratory failure, systemic metabolic derangement, symptoms of recurrent infection |
| 7. Signs | Severe tachycardia, hypotension, and oliguria; Revised Baux 80~100; signs of multiple organ dysfunction; generalized edema |
| 8. Screening | TBSA calculation; Revised Baux; SOFA score; bronchoscopy for inhalation injury; bacterial culture surveillance |
| 9. Diagnosis | Whole-body burn map; staged surgical planning; intensive ICU monitoring; diagnosis of recurrent sepsis |
| 10. Treatment | High-volume Parkland fluids; allografts, CEA, and artificial skin; beta-blockers; intensive nutrition and ICU management |
| 11. Prognosis | Survival 60~70% in specialized centers; long hospitalization of 3~5 months; causes of death are sepsis and multiple organ failure; long-term rehabilitation after survival |
| 12. Prevention | Building fire suppression systems; flame-resistant clothing; burn transfer network; fire safety education |
| 13. References | Sheridan RL et al. Comprehensive treatment of burns … and 9 other papers |
Burns of 50~59% TBSA were almost invariably fatal before the advent of modern medicine. Historically, burn patients with damage to more than half of the body's skin died within days from severe dehydration, infection, and systemic failure, and until the 19th century no effective treatment existed. In an era when the very concept of fluid resuscitation did not exist, circulatory collapse after large-area burns was fatal, and there were also no antibiotics against bacterial infection.
After the mid-20th century, the establishment of fluid resuscitation protocols, antibiotic therapy, and advances in general anesthesia and transfusion techniques made survival of 40~50% TBSA burns possible for the first time. The decisive turning point was the cultured epithelial autograft (CEA) technique published in 1979 by Janine Burke and Howard Green. This technique cultures keratinocytes harvested from the patient's own skin in vitro for 3~4 weeks to produce graftable cell sheets; in theory, a piece of skin the size of a postage stamp can produce skin sheets the size of a bathroom, an innovation that fundamentally solved the problem of donor site shortage.
In the 1980s~90s, Donald Herndon and colleagues at the Galveston burn center (Shriners Burns Institute, Galveston), located in San Antonio, Texas, established systematic treatment protocols for burns of 50% TBSA or more. As early excision and grafting, use of allograft skin, intensive nutritional support, modulation of the hypermetabolic response with beta-blockers, and rehabilitation-centered treatment were standardized, survival in burns of 50% TBSA or more improved greatly from 30~40% in the 1980s to 60~70% in the 2020s. Currently, clinical application of next-generation technologies such as 3D bioprinting, stem cell-based skin regeneration, and immunomodulatory therapy is under way.
Extremely severe burns reaching 50~59% TBSA occur mainly with exposure to large heat sources or chemicals in situations where escape is impossible. Large fires in enclosed spaces are the most common cause, occurring when escape routes are blocked in multistory building fires, in fires in underground facilities or windowless buildings, and in fires in mine shafts or tunnels. In these situations, simultaneous exposure to smoke and heat often results in combined inhalation injury and skin burns.
Flammable liquid explosions are cases in which highly flammable substances such as gasoline, thinner, LPG, and acetylene explode and the explosive flame instantly covers the whole body; explosions in confined spaces in particular cause extensive flame burns of 50% TBSA or more. Traffic accident fires arise from fuel tank rupture and ignition and vehicle interior fires, and large-area burns occur when escape is delayed or impossible. Major industrial accidents include chemical explosions, furnace explosions, and eruptions of molten metal. Risk factors include fires during sleep (delayed reaction), intoxication, limited mobility (people with disabilities, older adults), and inadequate fire safety equipment in old buildings.
In extremely severe burns of 50~59% TBSA, genetic background contributes importantly to interindividual differences in survival and the development of complications. Even among patients with burns of the same TBSA, marked individual differences appear in survival, timing of sepsis, rate of progression of multiple organ failure, and rate of wound healing, which are partly explained by genetic diversity. Polymorphisms of the Toll-like receptors (TLR2, TLR4), innate immune response genes, affect the function of pattern recognition receptors, creating individual differences in the response to pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) arising in burn wounds. Loss-of-function TLR4 polymorphisms increase the risk of Gram-negative sepsis.
Variants of coagulation-related genes (Factor V Leiden, Prothrombin 20210A, MTHFR) affect the tendency toward disseminated intravascular coagulation (DIC) and thrombus formation after burns, contributing to complications. Polymorphisms of renal function-related genes (APOL1, NPHS1) affect susceptibility to acute kidney injury (AKI) due to burn shock and fluid overload. To date, no single gene variant has been confirmed to determine the prognosis of burns of 50% TBSA or more, but genome-wide association studies (GWAS) are uncovering the genetic background in this field.
Burns of 50~59% TBSA are rare severe injuries accounting for about 3~5% of all burn admissions. When TBSA exceeds 50%, mortality rises sharply, reflecting the nonlinear relationship between burn area and mortality. For young adults (aged 20~40) treated in specialized burn centers, mortality for 50~59% TBSA burns is about 25~40%, rising by an additional 20~30% with inhalation injury. In older adults aged 60 and over, mortality for the same TBSA surges to 60~80%.
By the Revised Baux Score, a 30-year-old patient with 55% TBSA and no inhalation injury has a score = 30 + 55 = 85, with a predicted mortality of about 20~30%, and with inhalation injury the score is 85 + 17 = 102, with a predicted mortality reaching about 40~60%. For a 50-year-old patient with 55% TBSA, Baux = 105, and the risk of death is higher. The average hospital stay is 3~5 months, with an average of 6~10 operations, and total hospitalization costs in Korea can range from tens of millions to hundreds of millions of won. Application of the severe burn special copayment reduction (V247) limits the copayment to 5% for 1 year from the registration date, partly easing the economic burden on patients' families. According to long-term follow-up studies of survivors, return to work is possible in about 20~40%, requiring an average of 2~3 years of intensive rehabilitation.
In 50~59% TBSA burns, the systemic pathophysiology is a complex cascade affecting multiple organ systems simultaneously. Burn shock can progress rapidly to cardiac arrest if fluid resuscitation is not started immediately. Massive release of inflammatory mediators from the extensive wounds increases systemic capillary permeability to an extreme degree, and in theory high-volume fluid administration according to the Parkland formula (TBSA 55%, 70kg patient: 4 × 70 × 55 = 15,400mL) is needed. However, fluid administration at this level increases the risk of abdominal compartment syndrome, pulmonary edema, and worsening limb edema, so precise monitoring is essential.
In 50% TBSA burns, autologous donor sites are limited to 50% or less of the total skin, so there is an absolute shortage of autologous graft skin to cover all burn wounds at once. As a result, open wounds persist while wound closure is achieved in stages over weeks to months, and the risk of sepsis is very high. Recurrent sepsis is the most important complication in burns of 50% TBSA or more; the first episode of sepsis occurs 2~4 weeks after the burn and can recur until wound closure is complete. The main causative organisms of sepsis show a pattern in which staphylococci (especially MRSA) predominate early, followed in sequence by Pseudomonas aeruginosa, Acinetobacter baumannii, and Candida. Nutritional deficiency results from rapid protein and calorie consumption due to the hypermetabolic response, and without adequate nutrition, muscle wasting (sarcopenia) progresses rapidly.
Symptoms in patients with 50~59% TBSA burns are extremely severe and affect multiple organ systems. Immediately after the burn, patients experience severe pain and symptoms of shock, and some patients present with reduced pain sensation because of nerve damage or a state of severe shock. Extreme thirst, anxiety, and confusion are common, and without treatment they progress to decreased consciousness within hours. In addition to the burn sites, generalized edema, facial edema, and genital edema appear, and shoes or rings may become tight and obstruct blood flow.
Respiratory symptoms include dyspnea that may appear 24~72 hours after the burn regardless of inhalation injury, and mechanical ventilation often becomes necessary, particularly due to pulmonary edema from fluid overload or ARDS. During inpatient treatment, fever (sepsis), hypotension (septic shock), oliguria (AKI), jaundice (liver dysfunction), and decreased consciousness (cerebral hypoperfusion) may recur periodically. In the long term, severe muscle weakness, weight loss (possible loss of 20~30% of initial body weight), extreme fatigue, memory impairment and reduced concentration, and sleep disturbance persist.
Vital signs in 50~59% TBSA burns show severe abnormalities from the outset. Severe tachycardia (>120~140/min), hypotension (systolic 80~90mmHg), very severe tachypnea (>28~32/min), and almost no urine output (oliguria or anuria) are characteristic. The skin, including normal skin outside the burn areas, appears pale or mottled, and the limbs are cold due to reduced peripheral circulation. Cyanosis appears when oxygen saturation falls due to inhalation injury or ARDS. The Revised Baux Score falls in the range of 85~110 in most patients, indicating a high risk of death.
Blood tests show severe metabolic acidosis (pH < 7.2, lactate > 4mmol/L), severe hypoalbuminemia, electrolyte abnormalities (hyponatremia, hypocalcemia, hyperphosphatemia), a precipitous drop in platelets, and findings of DIC. A sharp rise in serum creatinine (AKI), elevated liver enzymes, and increased total bilirubin are early indicators of multiple organ dysfunction. Generalized edema causes abdominal distension and increased abdominal pressure (bladder pressure measurement when abdominal compartment syndrome is suspected), and extremely tight skin tension in the limbs suggests limb compartment syndrome.
Screening in 50~59% TBSA burns is an urgent assessment performed simultaneously with the start of resuscitation. Tests to be performed immediately include arterial blood gas analysis (including COHb), complete blood count, coagulation, electrolyte, renal function, liver function, and lactate tests, ECG, chest X-ray, and bladder pressure measurement. The Revised Baux Score is calculated immediately to communicate the prognosis and determine treatment intensity. If inhalation injury is suspected, bronchoscopy is performed immediately, and if there are findings of inhalation injury, early endotracheal intubation is decided. The SOFA score is calculated to quantify the degree of multiple organ dysfunction and to track treatment response. Initial bacterial surveillance cultures of the burn wounds are performed and then repeated 2~3 times a week.
The whole-body burn map is a key document to be shared by the entire burn treatment team, recording in detail the depth and area of each region on the Lund-Browder chart. In burns of 50% TBSA or more, depth classification by region is directly linked to decisions on treatment priorities. Intensive ICU monitoring requires an arterial line (direct blood pressure measurement), a central venous catheter, an indwelling urinary catheter, and, if necessary, a pulmonary artery catheter or transesophageal echocardiography. The staged surgical plan is established considering functional importance, infection risk, and physiologic tolerance of surgery, so as not to exceed the maximum TBSA that can be excised in one operation (about 20%). When sepsis develops, it is diagnosed promptly by the Sepsis-3 criteria and antibiotic administration is started within 1 hour (hour-1 bundle).
Parkland fluid calculation for a 70kg patient with 55% TBSA: 4 × 70 × 55 = 15,400mL; this high volume is given over the first 24 hours with precise adjustment by urine output. To avoid fluid overload, modified resuscitation protocols (setting weight-based upper limits, early addition of colloid) have recently been introduced. In wound management, allograft skin is an essential resource in burns of 50% TBSA or more, serving to close wounds temporarily while autologous donor sites regenerate. CEA (cultured epidermal cells) become available after 3~4 weeks, and the wound area is gradually reduced as donor site harvesting is repeated. Artificial dermis is applied as stage 1 to areas requiring dermal reconstruction, and once neovascularization is complete, thin autologous skin is grafted as stage 2. Aggressive nutritional support targets protein 2.0~2.5g/kg/day and total calories 40~50kcal/kg/day, combined with insulin therapy (target blood glucose 140~180mg/dL) and beta-blockers (propranolol 1~4mg/kg/day).
Survival in 50~59% TBSA burns is about 60~70% in specialized burn centers, a great improvement over 30~40% in the 1980s. The most common cause of death is sepsis/septic shock (50~60%), followed by ARDS and multiple organ failure (20~30%) and early respiratory failure due to inhalation injury (10~15%). Timing of death shows two peaks: within 1 week after the burn (burn shock, airway injury) and weeks 2~6 (sepsis, multiple organ failure). In burns of 50% TBSA or more, predicted mortality tends to rise by an additional 15~20% for each 10% increase, making TBSA the strongest predictor of prognosis. The average hospital stay of survivors is 3~5 months, and outpatient rehabilitation continues for 1~3 years after discharge. Hypertrophic scars and contractures occur in more than 80% of survivors, requiring multiple reconstructive operations. The incidence of PTSD reaches 40~55%.
Burns of 50% TBSA or more mostly occur in accidents that are structurally preventable. Installing automatic sprinkler systems in buildings is the most effective means of fundamentally preventing large-area burns by extinguishing flames within minutes after a fire starts. Early warning from fire alarm systems secures evacuation time and prevents burns of 50% TBSA or more from occurring in the first place. Flame-resistant clothing (FRC) delays ignition and burning time, increasing the success rate of evacuation. Fire evacuation education and drills are important, particularly regular drills in facilities for vulnerable groups (facilities for older adults, facilities for people with disabilities). Building a system for rapid transfer to specialized burn centers when burns occur, starting Parkland fluids before transfer, and educating medical staff and the public in correct first aid (20 minutes of cooling, immediate removal of the heat source) improve the quality of initial treatment and the final prognosis.
Sheridan RL, Tompkins RG, Burke JF. Management of burn wounds with prompt excision and immediate closure. J Intensive Care Med. 1994;9(1):6-19. DOI: 10.1177/088506669400900102. PMID: 10148968.
Herndon DN, Barrow RE, Rutan TC, et al. A comparison of conservative versus early excision therapies in severely burned patients. Ann Surg. 1989;209(5):547-553. DOI: 10.1097/00000658-198905000-00004. PMID: 2719964.
Osler T, Glance LG, Hosmer DW. Simplified estimates of the probability of death after burn injuries: extending and updating the Baux score. J Trauma. 2010;68(3):690-697. DOI: 10.1097/TA.0b013e3181c453b3. PMID: 20220427.
Jeschke MG, van Baar ME, Choudhry MA, et al. Burn injury. Nat Rev Dis Primers. 2020;6(1):11. DOI: 10.1038/s41572-020-0145-5. PMID: 32054846.
Greenhalgh DG. Sepsis in the burn patient: a different problem than sepsis in the general population. Burns Trauma. 2017;5:23. DOI: 10.1186/s41038-017-0089-9. PMID: 28748182.
Rousseau AF, Losser MR, Ichai C, Berger MM. ESPEN endorsed recommendations: nutritional therapy in major burns. Clin Nutr. 2013;32(4):497-502. DOI: 10.1016/j.clnu.2013.02.012. PMID: 23582468.
Wolf SE, Rose JK, Desai MH, Mileski JP, Barrow RE, Herndon DN. Mortality determinants in massive pediatric burns. An analysis of 103 children with greater than or equal to 80% TBSA burns. Ann Surg. 1997;225(5):554-569. DOI: 10.1097/00000658-199705000-00012. PMID: 9193182.
Brusselaers N, Monstrey S, Vogelaers D, Hoste E, Blot S. Severe burn injury in Europe. Crit Care. 2010;14(5):R188. DOI: 10.1186/cc9300. PMID: 20958964.
Hart DW, Wolf SE, Mlcak R, et al. Persistence of muscle catabolism after severe burn. Surgery. 2000;128(2):312-319. DOI: 10.1067/msy.2000.108059. PMID: 10923011.
Alvarado R, Chung KK, Cancio LC, Wolf SE. Burn resuscitation. Burns. 2009;35(1):4-14. DOI: 10.1016/j.burns.2008.03.008. PMID: 18675523.